))
Rahul Dhanda _e.039
Manage episode 373800057 series 3006114
Treść dostarczona przez John Flavin. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez John Flavin lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
e.039 was recorded in front of a whole audience of ppl in dorchester because that seemed like a pretty fun idea. in this episode, Rahul Dhanda (founder, ceo & prez of Syntis Bio) gives us the story of his career; teaches us a few lessons on #biotech research, startup creation & culture development; and he breaks DOWN the trap and residual harm of siloes in innovation.
Rahul Dhanda is co-founder, CEO and director of Syntis Bio - a team we love and cherish. previously, Rahul co-founded Sherlock Biosciences, where he was CEO, president and director, and built a diverse team that launched the first CRISPR product authorized by the FDA. an advocate of equity in society and STEM, Rahul founded The 221b Foundation, a non-profit providing CRISPR intellectual property in exchange for profit sharing to promote gender and racial equity in STEM.
named to boston’s Power50 list by the Boston Business Journal, Rahul also led Sherlock to recognition as a Fast Company Most Innovative Company, a Red Herring Top 100 Company, Fierce15 MedTech, Tech Pioneer by the World Economic Forum, and Top 50 Innovative Company by BostonInno. not everyone gets named to even one list in their life...so thts pretty wild.
Rahul holds an MBA from MIT’s Sloan School of Management, a B.A. from Wesleyan University, and authored the first book addressing the crossroads between industry and bioethics, entitled Guiding Icarus: Merging Bioethics with Corporate Interests.
ok thts all u should need, now get outta here...go listen !!
60 odcinków
Udostępnij
